Semi-Annual Balance Sheet

OncoTherapy Science, Inc. - Filing #7595079

Concept As at
2022-06-30
As at
2022-03-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,505,994,000 JPY
1,836,906,000 JPY
Other
141,873,000 JPY
113,764,000 JPY
Current assets
1,957,913,000 JPY
2,600,551,000 JPY
Non-current assets
Property, plant and equipment
JPY
17,000 JPY
Property, plant and equipment
Buildings
568,281,000 JPY
568,281,000 JPY
Buildings, net
JPY
JPY
Accumulated depreciation and impairment
-568,281,000 JPY
-568,281,000 JPY
Machinery and equipment
65,503,000 JPY
65,503,000 JPY
Machinery and equipment, net
JPY
JPY
Accumulated depreciation and impairment
-65,503,000 JPY
-65,503,000 JPY
Tools, furniture and fixtures
1,161,791,000 JPY
1,161,040,000 JPY
Tools, furniture and fixtures, net
JPY
17,000 JPY
Accumulated depreciation and impairment
-1,161,791,000 JPY
-1,161,022,000 JPY
Investments and other assets
Investments and other assets
84,630,000 JPY
84,630,000 JPY
Non-current assets
84,630,000 JPY
84,648,000 JPY
Assets
2,042,544,000 JPY
2,685,199,000 JPY
Liabilities
Current liabilities
Income taxes payable
34,133,000 JPY
136,533,000 JPY
Other
39,837,000 JPY
24,008,000 JPY
Current liabilities
272,930,000 JPY
604,923,000 JPY
Accounts payable - other
196,651,000 JPY
422,113,000 JPY
Non-current liabilities
Non-current liabilities
100,316,000 JPY
100,041,000 JPY
Asset retirement obligations
99,992,000 JPY
99,703,000 JPY
Liabilities
373,247,000 JPY
704,965,000 JPY
Other liabilities
Deferred tax liabilities
324,000 JPY
338,000 JPY
Other liabilities
Net assets
Share capital
789,114,000 JPY
789,114,000 JPY
Shareholders' equity
Capital surplus
Capital surplus
24,793,617,000 JPY
24,793,617,000 JPY
Retained earnings
Retained earnings
-23,963,978,000 JPY
-23,686,179,000 JPY
Shareholders' equity
1,618,753,000 JPY
1,896,553,000 JPY
Net assets
1,669,297,000 JPY
1,980,233,000 JPY
Share acquisition rights
50,543,000 JPY
83,680,000 JPY
Liabilities and net assets
2,042,544,000 JPY
2,685,199,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.